Legend Financial Advisors’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-199
Closed -$4.82K 128
2025
Q2
$4.82K Buy
+199
New +$4.64K ﹤0.01% 140
2025
Q1
Sell
-544
Closed -$14.4K 188
2024
Q4
$14.4K Buy
544
+345
+173% +$9.36K 0.01% 99
2024
Q3
$5.75K Sell
199
-345
-63% -$10.1K ﹤0.01% 122
2024
Q2
$15.2K Buy
+544
New +$15K 0.01% 120
2024
Q1
Sell
-199
Closed -$5.72K 195
2023
Q4
$5.72K Hold
199
﹤0.01% 145
2023
Q3
$6.6K Hold
199
0.01% 151
2023
Q2
$7.29K Hold
199
0.01% 166
2023
Q1
$8.11K Sell
199
-759
-79% -$32.8K 0.01% 168
2022
Q4
$49.1K Hold
958
0.04% 72
2022
Q3
$41.9K Buy
+958
New +$46.6K 0.04% 70

Other funds holding PFE

Legend Financial Advisors's PFE Position: Q3 2025 in Review

Legend Financial Advisors sold out of Pfizer (PFE) in Q3 2025, closing a stake of 199 shares — an estimated $4.82K sold.

Legend Financial Advisors first reported a position in PFE in Q3 2022 and held it in 10 quarters. The position peaked at $49.1K in Q4 2022. 2,812 funds tracked by Wall St. Rank hold PFE as of Q3 2025.

  • Legend Financial Advisors reported no remaining Pfizer position as of Q3 2025 after selling out during the quarter.
  • Legend Financial Advisors sold 199 Pfizer shares in Q3 2025, an estimated $4.82K.
  • Legend Financial Advisors first reported a position in Pfizer in Q3 2022 and held it in 10 quarters.
  • Legend Financial Advisors's Pfizer position peaked at $49.1K in Q4 2022.
  • 2,812 funds tracked by Wall St. Rank held Pfizer as of Q3 2025.

Based on Legend Financial Advisors's 13F filing for Q3 2025, filed 4 Nov 2025.